About toSense
toSense is a Technology company based in San Diego (United States) founded in 2014, and was acquired by Baxter in April 2020. Body worn sensor to remotely monitor chronic diseases vitals, EvoNexus Alum. It operates in the Technology and Healthcare sectors. toSense has raised $4.53 million across 2 funding rounds from investors including Baxter. Its chief executive, as recorded, is Bobby Kandaswamy. toSense offers products and services including Infusion Pumps, Nutritional Care Products, and Respiratory Therapies. Its focus areas include High Tech, Wearable Technology, Health and Wellness Devices and Cardiac. Its competitors include iRhythm Tech, AliveCor and iHealth Labs; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2014 and based in San Diego, United States, toSense operates in the health technology sector. A necklace integrated with sensors is developed to measure thoracic impedance, heart rate, heart rate variability, respiration rate, skin temperature, and posture during short wear periods. Data collected is transmitted to medical professionals for remote oversight, supporting reduced hospital readmissions for chronic conditions.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsTechnologyHealthcare
- Website tosense.com
- Social LinkedIn
- Acquired by Baxter (Apr 2020)
Products & Services of toSense
toSense offers a comprehensive portfolio of products and services, including Infusion Pumps, Nutritional Care Products, and Respiratory Therapies.
Devices for delivering treatments like chemotherapy to patients.
Solutions for patients unable to eat normally in hospitals.
Products that simplify delivery of breathing support at home.
Funding Insights of toSense
toSense has successfully raised a total of $4.53M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $750 thousand completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.53M
- Total Rounds 2
- Last Round Series A — $750,000
- First Round $3.78M
(Jun 2016)
All 2 funding rounds of toSense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2018 | $750,000 | Series A | – | – | – |
| Jun 2016 | $3.78M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in toSense
toSense has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Baxter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biosciences, medication delivery, and renal products are developed and marketed. | 1931 | baxter.com | Deerfield, United States |
Investor details for toSense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of toSense
1 people are tracked at toSense (1 in leadership).
| Name | Role | Group |
|---|---|---|
Bobby Kandaswamy | CEO | Leadership |
Complete people profiles for toSense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of toSense
4 dated milestones of toSense across 6 years, from founding to its latest funding, stage changes and deals.
- Founded toSense is founded.
- Funding First funding round of $3.8M.
- Funding Latest funding round, Series A, of $750K.
- Exit Acquired by Baxter.
Competitors of toSense
toSense has 3 listed competitors in our database, 3 of them funded. They include iRhythm Tech, AliveCor and iHealth Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| irhythmtech.com | 2006 | San Francisco, United States | $109.23M | 1,657 | Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | |
| alivecor.com | 2010 | Mountain View, United States | $114.38M | 67 | Cardiac monitoring devices and applications are provided for heart health. | |
| ihealthlabs.com | 2010 | Mountain View, United States | $25M | 104 | Personal healthcare devices for vital monitoring are designed and produced. |
Detailed competitors of toSense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Industrial IoT & Smart Manufacturing
3 companies that operate in the same segment as toSense (Industrial IoT & Smart Manufacturing) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
AI-powered cloud-based vehicle tracking solutions are offered for fleet owners. | 2015 | San Francisco, California, United States | USD 915 M | USD 1.62 B | 5,792 | |
Cloud-based smart security cameras are manufactured for home use. | 1999 | Provo, Utah, United States | USD 172 M | USD 341.04 M | 11,275 | |
Cloud-based network infrastructure for IoT applications is provided. | 2004 | Boise, Idaho, United States | USD 154.85 M | USD 8.52 M | 165 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about toSense
toSense was founded in 2014 and raised its 1st funding round 2 years after it was founded.
toSense is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Bobby Kandaswamy is the CEO of toSense, as recorded in our data.
toSense is a funded company, having raised a total of $4.53M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.78M, raised on Jun 2016.
Founded in 2014 and based in San Diego, United States, toSense operates in the health technology sector. A necklace integrated with sensors is developed to measure thoracic impedance, heart rate, heart rate variability, respiration rate, skin temperature, and posture during short wear periods. Data collected is transmitted to medical professionals for remote oversight, supporting reduced hospital readmissions for chronic conditions.
toSense's top competitors include AliveCor, iRhythm Tech and iHealth Labs.
toSense offers Infusion Pumps, Nutritional Care Products, and Respiratory Therapies.
toSense has 1 investor. Key investors include Baxter.
Yes. toSense was acquired by Baxter in April 2020.